U.S. federal trademark · Serial No. 76477997
AquiaSFinX provides the discovery scientist with a set of integrated, automated platform modules capable of running up to 1,500 parallel conditions per day to identify pharmaceutically acceptable excipient mixtures to meet the challenge of delivery of poorly water soluble drugs for animal dosing This platform can be used in early discovery and lead optimization to provide a means of very rapidly entering poorly soluble drug candidates into animal dosing Such studies can be used to determine if a compound is a potential drug candidate or simply a lead from which improved candidates can be elaborated
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.